- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06053060
Evaluation of the Positioning of the Dynacup Cup "One C" Versus "Standard Dynacup" (DYNACUP)
Evaluation of the Positioning of the Dynacup Cup "One C" Versus Standard Dynacup
The ceramic-ceramic friction pair is widely used today in total hip arthroplasty, including fourth-generation ceramics which show the lowest wear rate. These have considerably reduced the risk of head fracture compared to previous generations; however, the risk of insert rupture persists with rates similar to those of third generation ceramics.
These ceramic fractures require complex revision surgery, which brings complications, exposing patients to the risk of third-body wear and tear related to persistent post-surgical debris. They are frequently due to an incorrect assembly of the ceramic causing intraoperative or early postoperative rupture. To fix this, manufacturers have developed pre-assembled cups in the factory. The Dynacup One C cup developed by Corin® corresponds to the pre-assembled version of the Dynacup cup, making it possible to eliminate the risk of anomaly during intraoperative assembly linked to the human factor and to offer patients with very small cups an adapted ceramic implant. A single study with a small sample compared the two implants (pre-assembled version [vs] modular version) clinically, radiologically and functionally without showing any significant difference. The lack of data in the literature comparing these two implants motivated us to conduct a randomized comparative study on a large sample of patients.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Patients eligible for a total hip arthroplasty with a ceramic-ceramic friction couple and scheduled for surgery will be included in this study after information and collection of written consent.
After randomization, a preoperative radiograph with a calibration ball will be taken to plan the prosthesis and identify the characteristics of the operated hip.
An x-ray of the pelvis with a 28 mm ball will be carried out the day after the intervention according to the same preoperative procedures in order to measure the postoperative radiographic parameters.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ile De France
-
Paris, Ile De France, France, 75020
- Groupe Hospitalier Dianconesses croix saint Simon
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult man and woman > 18 years old
- Indication for hip arthroplasty with a Dynacup One C or standard Dynacup cup
- Patient informed of the study and signed a consent form
Exclusion Criteria:
- Refusal to participate in the study
- Indication of a friction couple other than ceramic-ceramic
- Contraindication or the technical impossibility of implanting an impacted acetabular component
- Pregnant or breastfeeding women.
- Minor patients aged < 18 years
- Subjects not affiliated to the national health insurance or to an equivalent insurance
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: Standard Dynacup
Hip arthroplasty with a standard Dynacup cup
|
Randomisation
|
|
Other: Dynacup One C
Hip arthroplasty with a cup Dynacup One C
|
Randomisation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To Compare the positioning accuracy of the Dynacup One C (pre-assembled version) with that of the standard Dynacup.
Time Frame: Perioperative
|
Radiographic measurement of the position of the center of rotation of the final implant, its inclination and its anteversion, compared to the positioning planned before the intervention for the 2 types of implants.
|
Perioperative
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To describe the rate of intraoperative secondary re-impactions of both groups
Time Frame: Perioperative
|
Note the attempts at re-impactions for sensation of extrusion: after palpation with forceps of the bottom of the acetabulum (bone space - metal back for the standard Dynacups) or of its protruding periphery of the bone (for the pre-assembled versions) . ○ Note the operator's feeling before postoperative control X-ray on the good impaction of the acetabulum: at the bottom, doubtful or extrus. |
Perioperative
|
|
To describe the rate of intraoperative complications according to the type of implant
Time Frame: Perioperative
|
Describe the rate of intraoperative complications according to the type of implant:
|
Perioperative
|
|
To describe the rate of insufficient impaction of the acetabulum in both groups
Time Frame: Perioperative
|
Describe the rate of insufficient impaction of the acetabulum in the 2 versions
|
Perioperative
|
|
Indentify predictors for insufficient impaction of the acetabular implant
Time Frame: Perioperative
|
Look for predictive factors of insufficient impaction of the acetabular implant
|
Perioperative
|
Collaborators and Investigators
Investigators
- Principal Investigator: Simon MARMOR, MD, Groupe Hospitalier Diaconesses Croix Saint-Simon
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- ID RCB : 2020-A02843-36
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Arthropathy
-
Xiangya Hospital of Central South UniversityActive, not recruitingKnee Arthropathy | Hip Arthropathy | Ankle Arthropathy | Elbow Arthropathy | Shoulder ArthropathyChina
-
Ehab Ahmed MohamedNot yet recruitingCharcot Arthropathy of Hindfoot
-
Universidad de ZaragozaCompletedArthropathy of Knee | Arthropathy of HipSpain
-
Centre Hospitalier Universitaire de la RéunionCompletedArthropathy of Knee | Arthropathy of HipRéunion
-
Super Inspired LLCRecruitingArthropathy of Knee | Arthropathy of HipUnited States
-
Medical University of South CarolinaCompletedArthropathy of Knee | Arthropathy of HipUnited States
-
Hvidovre University HospitalCompletedArthropathy of Knee | Arthropathy of HipDenmark
-
University Hospital, MontpellierCompletedKnee Arthropathy | Hip ArthropathyFrance
-
Nova Scotia Health AuthorityAcadia UniversityNot yet recruitingKnee Arthropathy | Hip Arthropathy
-
The Hawkins FoundationCompletedOsteoarthritis | Hip Arthropathy | Shoulder ArthropathyUnited States
Clinical Trials on Randomisation Standard Dynacup or Dynacup One C
-
Rush University Medical CenterEnovisRecruitingKnee OsteoarthritisUnited States
-
Universidad Complutense de MadridCompleted
-
Medical University of WarsawMedical Research Agency, PolandNot yet recruiting
-
McGill University Health Centre/Research Institute...Faculty of Medicine Universitas PadjadjaranNot yet recruitingHealthy Volunteer | Breastfeeding | Tuberculosis InfectionIndonesia
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)Not yet recruitingBasal Cell Carcinoma | Squamous Cell Carcinoma | Nonmelanoma Skin CancerUnited States
-
NestléCompleted
-
Memorial Sloan Kettering Cancer CenterBristol-Myers SquibbCompletedLeukemia | Acute Lymphoblastic LeukemiaUnited States
-
Massachusetts General HospitalMillennium Pharmaceuticals, Inc.CompletedAcute Lymphoblastic Leukemia | Lymphoblastic Lymphoma | B-cell Adult Acute Lymphoblastic Leukemia | T-cell Adult Acute Lymphoblastic LeukemiaUnited States
-
Seoul National University HospitalTerminated
-
M.D. Anderson Cancer CenterCompleted